Understanding both the current performance of communicable disease control in Europe and the scale of the differences among systems is crucial to understanding its present performance and possible Europeanization. We attempt to identify the structure of authority in communicable disease control in each European Union (EU) member state. The primary sources of information were the competent bodies list posted on the European Centre for Disease Prevention and Control website and the Health in Transition reports produced by the European Observatory on Health Systems and Policies. Three key patterns emerge to answer the question of who does what. First, the landscape is full and crowded, with many actors involved. Second, the landscape is highly fragmented, with many organizations performing overlapping functions in each country. Third, regional patterns describe which types of organizations are assigned which functions. These full, fragmented, and regionally disparate systems show no signs of constituting a shared model. As a result, if there is an EU model of communicable disease control today, it is at most an aspiration.

This content is only available as a PDF.

References

References
Allin, S. et al.
2004
.
Making Decisions on Public Health: A Review of Eight Countries
.
Brussels
:
European Observatory on Health Systems and Policies
.
Ammon, A.
2005
.
“Strukturen der Überwachung und des Managements von Infektionskrankheiten in der EU” [“Structure of the Surveillance and Management of Infectious Diseases in the European Union”]
.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
48
, no.
9
:
1038
42
.
doi:10.1007/s00103-005-1122-6
.
Baldwin, Peter.
2005
.
Disease and Democracy: The Industrialized World Faces AIDS
.
Berkeley
:
University of California Press
.
Bernitz, B. K.
2008
.
“Communicable Disease Policy Development in Response to Changing European Political Frontiers in Finland, Norway, and Sweden.”
Scandinavian Journal of Public Health
36
, no.
8
:
875
78
.
doi:10.1177/1403494808089651
.
Binder, S. et al.
2008
.
“National Public Health Institutes: Contributing to the Public Good.”
Journal of Public Health Policy
29
, no.
1
:
3
21
.
doi:10.1057/palgrave.jphp.3200167
.
Binder, S.; Adigun, L. E.; Greenspan, A. L..
2008
.
“NPHI Creation: Lessons Learned and Future Directions.”
Journal of Public Health Policy
29
, no.
4
:
459
66
.
doi:10.1057/jphp.2008.33
.
Carpenter, D. P.
2001
.
The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862 – 1928
.
Princeton, NJ
:
Princeton University Press
.
Coker, R. J.; Atun, R. A.; McKee, M..
2004
.
“Health-Care System Frailties and Public Health Control of Communicable Disease on the European Union's New Eastern Border.”
Lancet
363
, no.
9418
:
1389
92
.
doi:10.1016/S0140-6736(04)16053-4
.
EuroHealthNet
.
n.d.
“Reviewing Public Health Capacity in the EU.”
eurohealthnet.eu/research/public-health-capacity-eu
(accessed May 26, 2011)
.
European Centre for Disease Prevention and Control (ECDC)
.
n.d.
“Competent Bodies.”
Stockholm
:
ECDC
. ecdc.europa.eu/en/aboutus/organisation/Pages/AboutUs_CompetentBodies.aspx
(accessed May 1, 2010)
.
———.
n.d.
“Director and Director's Cabinet.”
Stockholm
:
ECDC
. ecdpc.europa.eu/About_us/Directors_Cabinet.html
(accessed May 1, 2010)
.
———.
n.d.
“Mission.”
Stockholm
:
ECDC
. www.ecdc.europa.eu/en/aboutus/Mission/Pages/Mission.aspx
(accessed December 5, 2010)
.
European Observatory on Health Systems and Policies
.
2010
.
Health Systems in Transition (HiT) Series
. www.euro.who.int/en/who-we-are/partners/observatory/health-systems-in-transition-hit-series/countries
(accessed February 1 – May 15, 2010)
.
Fidler, D. P.
2003
.
“SARS: Political Pathology of the First Post-Westphalian Pathogen.”
Journal of Law, Medicine and Ethics
31
, no.
4
:
485
505
.
doi:10.1111/j.1748-720X.2003.tb00117.x
.
Greer, S. L.
2009
.
The Politics of European Union Health Policies
.
Buckingham, UK
:
Open University Press
.
doi:10.1177/0958928708091056
.
Holland, W.; Mossialos, E..
1999
.
Public Health Policies in the European Union
.
Aldershot, UK
:
Ashgate
.
Kara-Zaitri, C.; ter Waarbeek, H..
2010
.
“Crossborder Infectious Disease Surveillance in the Netherlands, Germany, and Belgium.”
International Journal of Infectious Diseases
14
:
e280
.
doi:10.1016/j.ijid.2010.02.2108
.
Krapohl, S.
2008
.
Risk Regulation in the Single Market: The Governance of Pharmaceuticals and Foodstuffs in the European Union
.
Basingstoke, UK
:
Palgrave Macmillan
.
MacLehose, L.; McKee, M.; Weinberg, J..
2002
.
“Responding to the Challenge of Communicable Disease in Europe.”
Science
295
, no.
5562
:
2047
50
.
doi:10.1126/science.1070025
.
Pollitt, Christopher et al.
2004
.
Agencies: How Governments Do Things through Semi-autonomous Organizations
.
Basingstoke, UK
:
Palgrave Macmillan
.
Reintjes, R. et al.
2007
.
“Benchmarking National Surveillance Systems: A New Tool for the Comparison of Communicable Disease Surveillance and Control in Europe.”
European Journal of Public Health
17
, no.
4
:
375
80
.
doi:10.1093/eurpub/ckl256
.
Stefler, D.; Bhopal, R..
2010
.
“Comparison of the Hungarian and Scottish Communicable Disease Control Systems: Lessons for a Convergent European Community.”
Public Health
124
, no.
3
:
167
73
.
doi:10.1016/j.puhe.2010.02.005
.
Talbot, C.
2004
.
“The Agency Idea: Sometimes Old, Sometimes New, Sometimes Borrowed, Sometimes Untrue.”
In
Unbundled Government: A Critical Analysis of the Global Trend to Agencies, Quangos, and Contractualisation
, ed. Pollitt, C.; Talbot, C.,
3
21
.
Abingdon, UK
:
Routledge
.